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The aim of present study was to determine the effect of estrogen treatment on blood-brain barrier permeability in rats 
with induced global cerebral ischemia. The study included six-month-old female Sprague–Dawley rats which were 
divided into the following groups: Control-Ischemia-Reperfusion (C + I-R); Ovariectomy-Ischemia-Reperfusion 
(Ovx + I-R); Ovariectomy + Estrogen + Ischemia-Reperfusion (Ovx + E + I-R); Ovariectomy + Ischemia-
Reperfusion + Estrogen (Ovx + I-R + E). Ischemia-reperfusion was induced by clamping two carotid arteries, then 
opening the clamp. Blood-brain barrier permeability was visualized by Evans Blue extravasation and quantified by 
spectrophotometry. Our results indicate that following ischemia-reperfusion the BBB permeability is increased in 
ovariectomized rats (Evans Blue extravasation) compared to the control group in the cortex, thalamus, hippocampus, 
cerebellum and brain stem, while in the midbrain no significant increase was detected. In contrast, BBB permeability 
in the groups treated with estrogen, administered either before or after ischemia-reperfusion, was significantly lower 
than in ovariectomized animals. In conclusion, the increase in BBB permeability resulting from experimentally 
induced cerebral ischemia was prevented by exogenous estrogen treatment. The study results indicate that estrogen 
may be used for therapeutic purposes in ischemia-reperfusion.
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Blood-brain barrier (BBB), a physical and metabolic barrier between the central nervous 
system and peripheral circulation, is critical in the protection of brain homeostasis. The 
original structure of BBB is a highly specialized tight junction (17). The integrated function 
of the cerebral microvasculature, tight junction proteins, brain microvascular endothelial 
cells, cellular transport pathways, and enzymatic machinery jointly contribute to normal 
BBB integrity. Aging, systemic diseases, and ischemic injury can disrupt these processes, 
resulting in a decline in overall BBB function and integrity (22). Alterations to hormone 
levels at the onset of menopause and as a result of estrogen treatment may cause further 
changes in BBB functions (17). Besides, there are data suggesting that aging and hormonal 
alterations cause changes in the BBB tight junction integrity (2, 3, 9). It has been reported 
that replacement with physiological levels of estradiol protects against stroke-related injury 
in young and aging female rats and older animals remain responsive to the protective actions 
of estradiol (10). It was assumed that changes in estrogen levels or receptor activity may 
impair the tight junction in the BBB with aging. The two main types of estrogen receptors, 
ERα and ERβ, through which estrogen exerts its effect, are found commonly in microvascular 
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beds (14, 20). It was reported in previous studies that 17β-estradiol had favorable effects on 
cerebral circulation and it exerted these effects on the vascular tone, inflammation, and 
reactive oxygen types (11, 13).
The objective of the present study was to determine the effect of estrogen administration 
to 6-month-old ovariectomized rats before and after cerebral ischemia-reperfusion on BBB 
permeability in different areas of the brain such as cortex, thalamus, hippocampus, corpus 
striatum, midbrain, cerebellum, and brain stem.
Materials and Methods
This study was carried out at the Selcuk University Experimental Medicine Research and 
Application Center and at the Istanbul University, Istanbul Medical School, Department of 
Physiology. It was approved by the local ethical committee of the Selcuk University 
Experimental Medicine Research and Application Center, where the ovariectomy procedure 
was performed. Cerebral ischemia-reperfusion and BBB experiments were carried out at 
Istanbul University, Istanbul Medical School, Department of Physiology and approved by the 
local ethical committee. The study included 30 adult female rats of Sprague–Dawley strain, 
which were 6 months old and weighed 200–250 g. The rats were kept at 18–21 °C (room 
temperature), under 12 hours light/dark cycle (07.00 am–07.00 pm) and their food was 
provided in special steel bowls and their water (normal tap water) in glass feeding bottles. 
The animals were given about 10 g food per 100 g of body weight daily. Our study was 
performed using experimental groups as follows. Ischemia and reperfusion procedure and 
estradiol supplementation were performed 3 weeks after ovariectomy. The experimental 
groups of our study were as follows:
1. Control-Ischemia-Reperfusion (C + I-R; n = 7): Without any other procedure, the 
animals in this group were subjected to ischemia for 20 minutes and then to reperfusion for 
another 20 minutes, and decapitated. Brain tissues of the decapitated animals were removed 
without delay. Animals in this group were in the proestrus phase of the cycle.
2. Ovariectomy-Ischemia-Reperfusion (Ovx + I-R; n = 7): This group included the 
animals which were ovariectomized and then subjected to ischemia and reperfusion, for 20 
minutes each, like the control group, and decapitated. After decapitation, relevant brain 
tissues were removed.
3. Ovariectomy + Estrogen + Ischemia-Reperfusion (Ovx + E + I-R; n = 8): The 
animals in the group were ovariectomized and then injected with 10 µg/100 g body weight 
intraperitoneal 17β-estradiol before ischemia-reperfusion (2 hours before ischemia). The 
injection was followed by ischemia-reperfusion.
4. Ovariectomy + Ischemia-Reperfusion + Estrogen (Ovx + I-R + E; n = 8): The 
ovariectomized rats in this group were given 17β-estradiol treatment (10 µg/100 g body 
weight) 1 hour after ischemia-reperfusion.
Ovariectomy
Ovariectomy was performed in rats under general anesthesia with intramuscular ketamine 60 
mg/kg [Ketamin hydrochloride, Eczacibasi, Turkey, and Xylasine 5 mg/kg (Rompun, Bayer, 
Germany)]. The hair on the back of the rats was shaved for ovariectomy. Following 
appropriate asepsis and antisepsis with Betadine (Sanofi), the rats were placed in the ventral 
position and the skin was incised from 1/3 upper point of the stretch between the medial part 
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of the back and tail. After subcutaneous tissues were freed, peritoneal cavity was accessed 
through abdomen on back wall muscles. Ovaries were taken out together with lipid tissue. 
The ovaries were cleared of the lipid tissue, and then clamped, ligated and cut. After 
controlling the hemorrhage, other organs were replaced into the peritoneal cavity and the 
muscle was sutured with 2/0 chrome catgut and the skin with 2/0 silk (21).
Induction of ischemia-reperfusion
In order to induce global cerebral ischemia, the animals were put under general anesthesia 
with pentobarbital sodium. After clamping both carotid arteries for 20 minutes, 3 to 4 ml 
blood was taken, and blood pressure was dropped to 50 mmHg. All rats were anesthetized 
with pentobarbital sodium 35 mg/kg intraperitoneally (i.p.) and catheters filled with 100 IU 
of heparin in isotonic saline were inserted into bilateral femoral arteries and veins. One of the 
femoral artery was used for blood withdrawal the other for continuous monitoring (polygraph 
system-Nihon–Kohden, Tokyo, Japan) of mean arterial blood pressure. Reperfusion was 
induced by opening the clamp and the withdrawn blood in the syringe was re-infused slowly. 
Reperfusion was lasted for 20 min. The animals in all groups were sacrificed by decapitation 
2 hours after the procedures and brain tissue samples were collected without any delay. After 
the anesthesia, 3 ml×kg–1 2% Evans Blue (EB) solution was injected intravenously for visual 
examination of blood brain barrier disruption and for spectrophotometric measurements.
Changes in blood-brain barrier permeability
Spectrophotometric Evans Blue quantification
EB distribution was determined by spectrophotometric method. The perfused brains were 
removed and different brain areas (cortex, thalamus, hippocampus, corpus striatum, midbrain, 
cerebellum, and brain stem) were separated. Tissues taken from each brain area were kept in 
aluminum foil until the time of analysis. At the time of analysis, the samples were homogenized 
with 50% trichloroacetic acid and centrifuged at 15000 rpm for 20 minutes. The absorbance 
values were measured at 615 nm. EB values were calculated as µg dye×g–1 wet weight 
(1, 16).
Statistics
Values are expressed as the mean EB value in µg.g–1+. The data were analyzed using a one-
way ANOVA test. The criterion for statistical significance was (p < 0.05) in all statistical 
evaluations.
Results
EB values in different brain areas of the study groups are presented in Table I. When EB 
values in the brain cortex area were examined, the Ovx + I-R group was found to have the 
highest values compared to other groups (p < 0.05). Control group EB levels were higher 
than those in the treated groups. An examination of the EB levels in thalamus area showed 
that the highest levels were found in the Ovx + I-R group (p < 0.05) and the lowest levels 
were in the Ovx + I-R + E group (p < 0.05). Similarly, hippocampus EB levels were the 
highest in the Ovx-I-R group and the lowest in the Ovx + E + I-R group (p < 0.05). Concerning 
the EB permeability values in corpus striatum area, it was found that the Ovx + I-R group had 
the highest permeability and the Ovx + I-R + E group had the lowest permeability (p < 0.05). 
EB permeability of the midbrain in the control and Ovx – I groups was higher than that in the 
groups receiving estrogen (p < 0.05). As for cerebellum EB permeability values, the Ovx + 
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I-R group had the highest and the Oxv + I-R + E group had the lowest values (p < 0.05). 
When the EB permeability values in the brain stem were addressed, it was seen that the Ovx 
+ I-R group had higher permeability values than all the other groups. This parameter was 
higher in the control group than in estrogen treatment groups. The lowest EB permeability 
values were found in the Ovx + I-R + E group (p < 0.05).
Table I. Evans Blue permeability levels in different brain areas (μg dye × g−1 wet tissue)
Groups Cortex Thalamus Hippocampus Corpus 
striatum
Midbrain Cerebellum Brain stem
C + I-R 0.04±0.01b 0.15±0.09b 0.31±0.11b 0.36±0.07b 0.17±0.07a 0.12±0.06b 0.21±0.09b
Ovx + I-R 0.57±0.01a 0.36±0.02a 0.94±0.04a 0.58±0.02a 0.19±0.01a 0.21±0.07a 0.30±0.01a
Ovx + E+ 
I-R 0.02±0.03b 0.12±0.05b 0.10±0.05d 0.13±0.09c 0.10±0.04b 0.10±0.06b 0.10±0.03c
Ovx + I-R 
+ E 0.03±0.00b 0.03±0.00c 0.14±0.11c 0.11±0.17c 0.08±0.00b 0.04±0.00c 0.03±0.00d
Different letters in same column stand for significant differences  (P<0.05)  
(a > b >) for cortex significant difference between Ovx + I-R and C + I-R, Ovx + E + I-R, Ovx + I-R + E
(a > b > c >) for thalamus and cerebellum, significant difference between Ovx + I-R and C + I-R, Ovx + E + 
I-R, Ovx + I-R + E; significant difference between C + I-R, Ovx + E + I-R, and Ovx + I-R + E
(a > b > c > d) for hippocampus significant difference between Ovx + I-R and C + I-R, Ovx + E + I-R, Ovx + I-R 
+ E; significant difference between C + I-R and Ovx + E + I-R, Ovx + I-R + E; significant difference between Ovx 
+ I-R + E and Ovx + E + I-R
(a > b > c >) for corpus striatum significant difference between Ovx + I-R and C + I-R, Ovx + E + I-R, Ovx + 
I-R + E; significant difference between C + I-R and Ovx + E + I-R, and Ovx + I-R + E
(a > b >) midbrain significant difference between C + I-R, Ovx + I-R and Ovx + E + I-R, Ovx + I-R
(a > b > c > d) for brain stem significant difference between Ovx + I-R and C + I-R, Ovx + E + I-R, Ovx + I-R + 
E; significant difference between C + I-R and Ovx + E + I-R, Ovx + I-R + E; significant difference between Ovx + 
I-R + E and Ovx + E + I-R
C-I-R (Control-Ischemia-Reperfusion);
Ovx-I-R (Ovariectomized + Ischemia-Reperfusion);
Ovx + E + I-R (Ovariectomized + Estrogen + Ischemia-Reperfusion);
Ovx + I-R + E (Ovariectomized + Ischemia-Reperfusion + Estrogen)
Discussion
The first result of the present study is that ischemia induced in 6-month-old ovariectomized 
rats significantly increased the permeability of the BBB. However, estrogen treatment before 
and after ischemia-reperfusion following ovariectomy markedly restored the impairments in 
the blood-brain barrier. Still, while estrogen treatment before ischemia reperfusion produced 
more favorable effects in the blood-brain barrier in some brain areas, estrogen treatment after 
ischemia-reperfusion brought about greater improvements in the BBB function in other 
brain areas.
The brain and its vascular structures are strong targets of estrogen. Therefore, age-
related decreases in estrogen levels and changes in estrogen receptors damage the integrity of 
the blood-brain barrier as a result of which toxic products pass into the brain and harmful 
effects may arise (3). Similarly, estrogen was reported to perform a protective action against 
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brain injuries inflicted in different conditions and the resulting impairments to the blood-
brain barrier (5, 6). Age-related increases in the blood-brain barrier permeability were 
attributed to the loss of sex hormones in the serum (22). It was reported that ovariectomy 
caused an almost 2.2-fold increase in the Evans Blue permeability of the blood-brain barrier 
(22). In our study, BBB permeability significantly increased in all brain areas after 
ovariectomy, relative to the control group, and this result is parallel to the result of the above-
cited studies. It was suggested in previous studies that acute estrogen administration prevented 
the impairment to the BBB in ischemic rats (15). Estrogen levels may affect BBB structures 
and brain homeostasis with aging and lead to pathological conditions. In fact, Sandoval and 
Witt (18) examined the effects of age and 17β-estradiol on BBB tight junction permeability 
and estrogen receptor proteins. It was found in the concerned study that estrogen treatment 
influenced different tight junction proteins in different age groups (occludine in the young 
and claudine in the middle-aged), but did not have any impact on functional paracellular 
permeability. In our study, however, BBB permeability increased significantly in the 
ovariectomized ischemic group, and this result is different from the results of the above-cited 
study. In a study by Cipolla et al. (8) estrogen treatment to ovariectomized rats was found to 
significantly lower the permeability of the blood-brain barrier. Chi et al. (7) investigated the 
effect of 17β-estradiol on BBB permeability during focal cerebral ischemia. They found that 
ischemia and 17β-estradiol produced different effects on young (3-month-old) and old 
(24-month-old) Fischer rats. Ischemia did not affect the blood-brain permeability of young 
rats, whereas increased BBB permeability was found in both the ischemic cortex and 
contralateral cortex of old rats. However, no such effect was observed in young rats. Our 
study was conducted on 6-month-old rats and significant ischemia-related increases were 
found in cortical Evans Blue values which were studied as an indicator of BBB permeability. 
Thus, the result we obtained is in consistency with the results established in old rats in the 
previous study. 
Chi et al. (6) found in their study that prior treatment of ovariectomized rats with 21-day 
estrogen pellets before ischemia significantly restored the destruction caused by vascular 
endothelial growth factor in the BBB and this finding attests to the protective effect of 
estrogen.
In our study, ovariectomy was found to significantly increase BBB permeability in the 
hippocampus. However, estrogen treatment before and after ischemia-reperfusion following 
ovariectomy was seen to markedly restore the impairment to the BBB. In the same vein, 
previous studies demonstrated that estrogen treatment played a protective role against the 
hippocampus damage inflicted during global ischemia, and this result lends support to ours 
(4, 12).
We established in our study that Evans Blue permeability values in different brain areas 
such as corpus striatum, midbrain, brain stem, and cerebellum increased significantly after 
ovariectomy. In a similar, previous study, increased blood-brain barrier permeability was 
found in structures like frontal, temporal, parietal, and occipital cortices, as well as cerebellum 
and brain stem 1 week after ovariectomy (17). In our study, BBB, Evans Blue permeability 
values in experimental animals were determined in ischemia-reperfusion induced 3 weeks 
after ovariectomy and significantly elevated EB levels were established in different brain 
areas, while estrogen treatment before and after ischemia-reperfusion markedly restored the 
impairment to the structure of the BBB. These findings are parallel to results reported 
previously (19). 
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An overall assessment of the study results shows that cerebral ischemia in 6-month-old 
ovariectomized rats causes a significant increase in the BBB permeability. However, estrogen 
treatment before and after ischemia-reperfusion in experimental animals significantly 
prevented the increase in the blood-brain barrier permeability resulting from ovariectomy. In 
fact, estrogen treatment administered after ischemia was more effective in impeding the 
destruction in the brain areas other than the hippocampus. These results suggest that estrogen 
can be utilized for therapeutic purposes in pathological conditions which cause neuronal 
damage like ischemia-reperfusion.
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